Overview

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Status:
Completed
Trial end date:
2016-01-29
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the therapeutic efficacy and safety of DSXS and a Placebo in patients with moderate to severe scalp psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Taro Pharmaceuticals USA